Authors
Anshuman Elhence, Anany Gupta, Soumya Jagannath Mahapatra, Manpreet Uppal, Hariharan Iyer, Shivam Pandey, Anugrah Dhooria, Randeep Rana, Rajni Yadav, Deepak Gunjan, Anjan Trikha, S Arulselvi, Karan Madan, Pramod Kumar Garg
Published in
Pancreas. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Acute hypoxemic respiratory failure (AHRF) is the commonest organ failure in patients with severe acute pancreatitis (AP), a hyperinflammatory condition. However, its causes and pathophysiology, though often attributable to acute respiratory distress syndrome (ARDS), are not well-known.
We prospectively studied patients with severe AP and AHRF. These patients were evaluated with blood gas analysis, chest imaging including lung ultrasonography, computed tomography, and interleukin-6 (IL-6) levels in a subset of patients. The causes of AHRF were the primary outcome measure.
We included 297 patients with AP. Of them, 104 (35%) patients (mean age 37.4±14.4 y) developed AHRF: 65 (62.5%) had grade II, 27 (26.0%) had grade III and 12 (11.5%) had grade IV AHRF. Among those with AHRF, 24 (23%) met the criteria for ARDS, 10 (9.6%) had pleural effusion contributing to hypoxemia, and 4 (3.8%) had interstitial alveolar syndrome. However, the majority i.e., 63 (60.5%) patients had no radiologic correlate of AHRF and had signs of severe systemic inflammation, including high serum IL-6 levels. This was termed as 'Image-negative hyperinflammatory AHRF'. The mortality in patients with AHRF was 35.6%.
AHRF develops in one-third of patients with severe AP with a high mortality. The majority of patients have 'Image-negative hyperinflammatory AHRF'.
PMID:
43038375
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0